Literature DB >> 23215846

Introduction: Aerosol delivery of orally inhaled agents.

Timothy E Corcoran1, Sunalene G Devadason, Philip J Kuehl.   

Abstract

Deposition scintigraphy methods have been used extensively to provide qualitative and quantitative data on aerosol drug deposition in the lungs. However, differences in methodology among the different centers performing these studies have limited the application of these techniques, especially in regulatory roles. As an introduction to the standardized techniques developed by the International Society for Aerosols in Medicine (ISAM) Regulatory Affairs Networking Group, we present potential advantages of the use of standard techniques for deposition scintigraphy. Specifically, we propose that standardized techniques would allow for better comparisons between labs and would facilitate multicenter studies. They would allow for improved methods of establishing equivalence and could be better utilized to establish dosing for new medications. They would allow for the performance of more accurate dose ranging or multidose studies and complement pharmacokinetic studies of new inhaled medications. Standardized techniques could help to establish the relationship between the deposition of drug in the lungs and clinical effect, and may also facilitate clinical measurements of deposited dose for medications with narrow therapeutic indices. In the sections that follow, we discuss the best techniques used to perform deposition scintigraphy through planar, single-photon emission computed tomography, and positron emission tomography modalities and propose a detailed set of standardized methods for each. These include methods for radiolabel validation, radiolabel accountability and mass balance, and imaging acquisition and analysis.

Mesh:

Substances:

Year:  2012        PMID: 23215846      PMCID: PMC4227416          DOI: 10.1089/jamp.2012.1Su2

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  18 in total

Review 1.  Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung Institute, London 24 June 1994.

Authors:  D F Rogers; D Ganderton
Journal:  Respir Med       Date:  1995-04       Impact factor: 3.415

2.  Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report.

Authors:  Dennis O'Connor; Wallace P Adams; Mei-Ling Chen; Peter Daley-Yates; John Davis; Hartmut Derendorf; Murray P Ducharme; Anders Fuglsang; Myra Herrle; Günther Hochhaus; Susan M Holmes; Sau L Lee; Bing V Li; Svetlana Lyapustina; Stephen Newman; Martin Oliver; Beverley Patterson; Joanne Peart; Guirag Poochikian; Partha Roy; Tushar Shah; Gur Jai Pal Singh; Sandra Suarez Sharp
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2011-03-31       Impact factor: 2.849

3.  The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma.

Authors:  B L Laube; A M Edwards; R N Dalby; P S Creticos; P S Norman
Journal:  J Allergy Clin Immunol       Date:  1998-04       Impact factor: 10.793

4.  The influence of aerosol retention and pattern of deposition on bronchial responsiveness to atropine and methacholine in humans.

Authors:  M K Gillett; B A Briggs; P D Snashall
Journal:  Am Rev Respir Dis       Date:  1989-12

5.  The acute respiratory distress syndrome.

Authors:  M A Matthay
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

6.  Deposition of inhaled particles in the mouth and throat of asthmatic subjects.

Authors:  K Svartengren; P A Lindestad; M Svartengren; G Bylin; K Philipson; P Camner
Journal:  Eur Respir J       Date:  1994-08       Impact factor: 16.671

7.  Dose-related reversal of acute lung rejection by aerosolized cyclosporine.

Authors:  A T Iacono; G C Smaldone; R J Keenan; P Diot; J H Dauber; A Zeevi; G J Burckart; B P Griffith
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

8.  Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers.

Authors:  Michael T Newhouse; Peter H Hirst; Sarma P Duddu; Yulia H Walter; Thomas E Tarara; Andrew R Clark; Jeffry G Weers
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

9.  Deposition of amphotericin B aerosols in pulmonary aspergilloma.

Authors:  P Diot; B Rivoire; A Le Pape; E Lemarie; D Dire; Y Furet; M Breteau; G C Smaldone
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

10.  Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.

Authors:  A Anzueto; R P Baughman; K K Guntupalli; J G Weg; H P Wiedemann; A A Raventós; F Lemaire; W Long; D S Zaccardelli; E N Pattishall
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.